ATC main groups
ATC group L: Antineoplastic and immunomodulating agents
ATC main group L (Antineoplastic and immunomodulating agents) holds 622 preparations on the Swiss Specialities List, 202 of them generics and 401 with a limitation. Public prices run from CHF 12.40 to CHF 141'688.60 per pack.
60 preparationsAs of 17/09/2026
This group holds 622 preparations. The table shows the first 60 alphabetically; the complete set is in the A-Z directory.
| Preparation | Authorisation holder | ATC | Type | Public price from | Limitation |
|---|---|---|---|---|---|
| Abevmy | Medius AG | L01FG01 | Biosimilar | CHF 254.30 | Yes |
| Abirateron Accord | Accord Healthcare AG | L02BX03 | Generic | CHF 992.05 | Yes |
| Abirateron Devatis | Devatis AG | L02BX03 | Generic | CHF 899.90 | Yes |
| Abirateron Sandoz | Sandoz Pharmaceuticals AG | L02BX03 | Generic | CHF 992.05 | Yes |
| Abirateron Spirig HC | Spirig HealthCare AG | L02BX03 | Generic | CHF 992.05 | Yes |
| Abirateron Viatris | Viatris Pharma GmbH | L02BX03 | Generic | CHF 992.05 | Yes |
| Abirateron Zentiva | Helvepharm AG | L02BX03 | Generic | CHF 992.05 | Yes |
| abnobaVISCUM Fraxini | Future Health Pharma GmbH | L01CX | Originator product | CHF 66.85 | No |
| Abraxane | Bristol-Myers Squibb SA | L01CD01 | Originator product | CHF 332.10 | Yes |
| Abrilada | Pfizer AG | L04AB04 | Biosimilar | CHF 419.95 | Yes |
| Accofil | Accord Healthcare AG | L03AA02 | Biosimilar | CHF 78.85 | Yes |
| Actemra | Roche Pharma (Schweiz) AG | L04AC07 | Reference product | CHF 116.80 | Yes |
| Adcetris | Takeda Pharma AG | L01FX05 | Originator product | CHF 3'263.75 | Yes |
| Adriblastin RD | Pfizer AG | L01DB01 | Originator product | CHF 32.10 | No |
| Adriblastin Sol | Pfizer AG | L01DB01 | Originator product | CHF 29.60 | No |
| Advagraf | Astellas Pharma AG | L04AD02 | Originator product | CHF 88.85 | No |
| Afinitor | Novartis Pharma Schweiz AG | L01EG02 | Originator product | CHF 1'144.90 | Yes |
| Akeega | Janssen-Cilag AG | L01XK52 | Originator product | CHF 4'523.30 | Yes |
| Alacare | Gebro Pharma AG | L01XD04 | Originator product | CHF 146.90 | Yes |
| Alecensa | Roche Pharma (Schweiz) AG | L01ED03 | Originator product | CHF 4'741.25 | Yes |
| Alimta | Eli Lilly (Suisse) SA | L01BA04 | Originator product | CHF 146.40 | Yes |
| Alkeran | Aspen Pharma Schweiz GmbH | L01AA03 | Originator product | CHF 48.25 | Yes |
| Alunbrig | Takeda Pharma AG | L01ED04 | Originator product | CHF 605.65 | Yes |
| Alunbrig Starterpackung | Takeda Pharma AG | L01ED04 | Originator product | CHF 4'730.25 | Yes |
| Ambiful | Curatis AG | L02BA03 | Generic | CHF 329.05 | Yes |
| Ameluz | Louis Widmer AG | L01XD04 | Originator product | CHF 199.75 | Yes |
| Amgevita | Amgen Switzerland AG | L04AB04 | Biosimilar | CHF 218.20 | Yes |
| Anastrozol Devatis | Devatis AG | L02BG03 | Generic | CHF 76.65 | No |
| Anastrozol Sandoz | Sandoz Pharmaceuticals AG | L02BG03 | Generic | CHF 76.65 | No |
| Anastrozol Zentiva | Helvepharm AG | L02BG03 | Generic | CHF 73.45 | No |
| Anastrozol-Teva | Teva Pharma AG | L02BG03 | Generic | CHF 76.65 | No |
| Apremilast Accord | Accord Healthcare AG | L04AA32 | Generic | CHF 131.05 | Yes |
| Apremilast Devatis | Devatis AG | L04AA32 | Generic | CHF 323.20 | Yes |
| Apremilast Devatis Starterpackung | Devatis AG | L04AA32 | Generic | CHF 161.60 | Yes |
| Apremilast Leman | Leman SKL SA | L04AA32 | Generic | CHF 281.15 | Yes |
| Apremilast Leman Starterpackung | Leman SKL SA | L04AA32 | Generic | CHF 141.10 | Yes |
| Apremilast Spirig HC | Spirig HealthCare AG | L04AA32 | Generic | CHF 323.20 | Yes |
| Apremilast Spirig HC Starterpackung | Spirig HealthCare AG | L04AA32 | Generic | CHF 161.60 | Yes |
| Apremilast-Mepha | Mepha Pharma AG | L04AA32 | Generic | CHF 323.20 | Yes |
| Apremilast-Mepha Starterpackung | Mepha Pharma AG | L04AA32 | Generic | CHF 161.60 | Yes |
| Arava | Sanofi-Aventis (Suisse) SA | L04AK01 | Originator product | CHF 29.20 | No |
| Arimidex | Medius AG | L02BG03 | Originator product | CHF 92.95 | No |
| Arimidex (PI) | APS-Arzneimittel-Parallelimport-Service AG | L02BG03 | Originator product | CHF 77.80 | No |
| Aromasin | Pfizer AG | L02BG06 | Originator product | CHF 91.85 | No |
| Aspaveli | Swedish Orphan Biovitrum AG | L04AJ03 | Originator product | CHF 2'958.95 | Yes |
| Atgam | Pfizer AG | L04AA03 | Originator product | CHF 3'058.50 | Yes |
| Atriance | Sandoz Pharmaceuticals AG | L01BB07 | Originator product | CHF 336.65 | Yes |
| Aubagio | Sanofi-Aventis (Suisse) SA | L04AK02 | Originator product | CHF 473.95 | No |
| Aubagio QOD | Sanofi-Aventis (Suisse) SA | L04AK02 | Originator product | CHF 473.95 | No |
| Avastin | Roche Pharma (Schweiz) AG | L01FG01 | Reference product | CHF 309.80 | Yes |
| Avonex | Biogen Switzerland AG | L03AB07 | Originator product | CHF 909.25 | No |
| Avonex Pen | Biogen Switzerland AG | L03AB07 | Originator product | CHF 909.25 | No |
| Avtozma | iQone Healthcare Switzerland SA | L04AC07 | Biosimilar | CHF 108.15 | Yes |
| Axitinib Sandoz | Sandoz Pharmaceuticals AG | L01EK01 | Generic | CHF 216.55 | Yes |
| Axitinib Spirig HC | Spirig HealthCare AG | L01EK01 | Generic | CHF 216.55 | Yes |
| Azacitidin Accord | Accord Healthcare AG | L01BC07 | Generic | CHF 259.95 | Yes |
| Azacitidin Ideogen | Ideogen AG | L01BC07 | Generic | CHF 223.75 | Yes |
| Azacitidin Sandoz | Sandoz Pharmaceuticals AG | L01BC07 | Generic | CHF 259.95 | Yes |
| Azacitidin Spirig HC | Spirig HealthCare AG | L01BC07 | Generic | CHF 259.95 | Yes |
| Azacitidin Stada | Spirig HealthCare AG | L01BC07 | Generic | CHF 253.90 | Yes |
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages
ATC main groups: FAQ
What is the ATC code?
The WHO Anatomical Therapeutic Chemical code classifies every active substance across five levels: anatomical main group (one letter), therapeutic subgroup, pharmacological and chemical subgroups, and the chemical substance. B01AC06, for example, is acetylsalicylic acid as a platelet aggregation inhibitor.
What is the difference between the ATC code and an IT group?
The ATC code is an international active substance classification. The IT group (indication therapy group) is the Swiss ordering of the Specialities List and serves the FOPH as the basis for the therapeutic cross comparison and for limitations that apply to a whole group.
What role does the ATC group play in price setting?
It helps identify comparator products. For the therapeutic cross comparison under Art. 65b of the Health Insurance Ordinance the FOPH uses medicines with the same indication or a similar mode of action, usually from the same ATC and IT group, and compares daily treatment costs.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages